Kidney acidosis drug study halted before it began
NCT ID NCT03831152
First seen Feb 10, 2026 · Last updated May 18, 2026 · Updated 15 times
Summary
This study was designed to test the long-term safety and effectiveness of a drug called ADV7103 for people with a rare kidney condition that causes too much acid in the blood (primary distal renal tubular acidosis). It planned to include children and adults, but the study was withdrawn before any participants were enrolled. No results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACIDOSIS, RENAL TUBULAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of South Florida Pediatric Infectious Diseases
Tampa, Florida, 33606, United States
Conditions
Explore the condition pages connected to this study.